Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins.

Polack FP, Lydy SL, Lee SH, Rota PA, Bellini WJ, Adams RJ, Robinson HL, Griffin DE.

Clin Vaccine Immunol. 2013 Feb;20(2):205-10. doi: 10.1128/CVI.00394-12. Epub 2012 Dec 12.

2.

A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles.

Pan CH, Greer CE, Hauer D, Legg HS, Lee EY, Bergen MJ, Lau B, Adams RJ, Polo JM, Griffin DE.

J Virol. 2010 Apr;84(8):3798-807. doi: 10.1128/JVI.01566-09. Epub 2010 Feb 3.

3.

Vaxfectin adjuvant improves antibody responses of juvenile rhesus macaques to a DNA vaccine encoding the measles virus hemagglutinin and fusion proteins.

Lin WH, Vilalta A, Adams RJ, Rolland A, Sullivan SM, Griffin DE.

J Virol. 2013 Jun;87(12):6560-8. doi: 10.1128/JVI.00635-13. Epub 2013 Apr 3.

4.

Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virus.

Pan CH, Jimenez GS, Nair N, Wei Q, Adams RJ, Polack FP, Rolland A, Vilalta A, Griffin DE.

Clin Vaccine Immunol. 2008 Aug;15(8):1214-21. doi: 10.1128/CVI.00120-08. Epub 2008 Jun 4.

5.

Vaccine-induced measles virus-specific T cells do not prevent infection or disease but facilitate subsequent clearance of viral RNA.

Lin WH, Pan CH, Adams RJ, Laube BL, Griffin DE.

MBio. 2014 Apr 15;5(2):e01047. doi: 10.1128/mBio.01047-14.

6.

Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.

Song MK, Vindurampulle CJ, Capozzo AV, Ulmer J, Polo JM, Pasetti MF, Barry EM, Levine MM.

J Virol. 2005 Aug;79(15):9854-61.

7.

Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody.

Zhu Yd, Rota P, Wyatt L, Tamin A, Rozenblatt S, Lerche N, Moss B, Bellini W, McChesney M.

Virology. 2000 Oct 10;276(1):202-13.

8.
9.

Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.

Stittelaar KJ, Wyatt LS, de Swart RL, Vos HW, Groen J, van Amerongen G, van Binnendijk RS, Rozenblatt S, Moss B, Osterhaus AD.

J Virol. 2000 May;74(9):4236-43.

10.

Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques.

Pan CH, Nair N, Adams RJ, Zink MC, Lee EY, Polack FP, Singh M, O'Hagan DT, Griffin DE.

Clin Vaccine Immunol. 2008 Apr;15(4):697-706. doi: 10.1128/CVI.00045-08. Epub 2008 Feb 20.

11.

Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles.

Pan CH, Valsamakis A, Colella T, Nair N, Adams RJ, Polack FP, Greer CE, Perri S, Polo JM, Griffin DE.

Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11581-8. Epub 2005 Jul 21.

12.

Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles.

Polack FP, Lee SH, Permar S, Manyara E, Nousari HG, Jeng Y, Mustafa F, Valsamakis A, Adams RJ, Robinson HL, Griffin DE.

Nat Med. 2000 Jul;6(7):776-81. Erratum in: Nat Med 2000 Sep;6(9):1062.

PMID:
10888926
13.

Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody.

Premenko-Lanier M, Rota PA, Rhodes GH, Bellini WJ, McChesney MB.

J Infect Dis. 2004 Jun 1;189(11):2064-71. Epub 2004 May 11.

14.
15.

Prior DNA vaccination does not interfere with the live-attenuated measles vaccine.

Premenko-Lanier M, Rota P, Rhodes G, Bellini W, McChesney M.

Vaccine. 2004 Jan 26;22(5-6):762-5.

PMID:
14741170
16.

Heterologous prime-boost strategy to immunize very young infants against measles: pre-clinical studies in rhesus macaques.

Pasetti MF, Resendiz-Albor A, Ramirez K, Stout R, Papania M, Adams RJ, Polack FP, Ward BJ, Burt D, Chabot S, Ulmer J, Barry EM, Levine MM.

Clin Pharmacol Ther. 2007 Dec;82(6):672-85. Epub 2007 Oct 31.

PMID:
17971812
17.
18.
19.

Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies.

van Binnendijk RS, Poelen MC, van Amerongen G, de Vries P, Osterhaus AD.

J Infect Dis. 1997 Mar;175(3):524-32.

20.

A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles.

Polack FP, Hoffman SJ, Crujeiras G, Griffin DE.

Nat Med. 2003 Sep;9(9):1209-13. Epub 2003 Aug 17.

PMID:
12925847
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk